Neogen (NEOG) Q3 2026 earnings — TrendMatrix coverage

Adjusted EPS

$0.08

Estimate

$0.05

Surprise

+50.0%

Score today

4.8/10

Revenue for this quarter isn’t shown: the reported figure hasn’t cleared TrendMatrix’s freshness and sanity checks yet, and consensus revenue isn’t tracked. EPS above is the available figure.

Neogen (NEOG) beat the $0.05 estimate with adjusted EPS of $0.08 — a large 50.0% upside surprise.

• 12 Health Care Stocks Moving In Wednesday's Pre-Market Session — benzinga, 2026-10-07
• Why Penguin Solutions Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket — benzinga, 2026-10-07
• Full Transcript: Neogen Q1 2027 Earnings Call — benzinga, 2026-10-06

TrendMatrix currently rates NEOG Sell at 4.8/10; no pre/post engine snapshot brackets this report.

4 of the last 4 quarters beat the estimate; this quarter's +50.0% surprise compares with a +56.9% four-quarter average.

This section and the ones below it reflect TrendMatrix’s latest engine read — they update after the report date and are not frozen to it.

Current price

$11.96

Price target

$13.97

Stop

$11.23

Upside to target

+16.8%

Model outputs from TrendMatrix’s engine as of 2026-10-07 — shown for context, not personalized investment advice.

Healthcare earnings trade on pipeline and payer dynamics as much as the quarter itself; a beat or miss is weighed against trial and reimbursement news.

Industry

Medical Devices

Market cap

$2.61B

P/E (fwd)

31.5

52-week range

$5.37–$14.26

Off 52-week high

16.1%

RSI (14)

45

Volume vs avg

1.23×

Score today

4.8/10